Your account is not claimed yet. You can sign up with ORCID to claim your account.

Marco Heestermans

ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Venues

Vascular health and risk management

Journal of clinical medicine

Thrombosis journal

Nature communications

INSERM U1176

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSERM U1176 Aug 1o 2020

France

Postdoc :: Hemostasis, Inflammation, Thrombosis

Publications

Geraldine Poenou, Teona Dumitru Dumitru, Ludovic Lafaie, Valentine Mismetti, Elie Ayoub, Cécile Duvillard, Sandrine Accassat, Patrick Mismetti, Marco Heestermans, Laurent Bertoletti
Pulmonary Embolism in the Cancer Associated Thrombosis Landscape. Journal of clinical medicine 11 (19) (2022)
Geraldine Poenou, Teona Dumitru Dumitru, Ludovic Lafaie, Valentine Mismetti, Marco Heestermans, Laurent Bertoletti
Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives. Vascular health and risk management 18 (2022)
Marco Heestermans, Geraldine Poenou, Hind Hamzeh-Cognasse, Fabrice Cognasse, Laurent Bertoletti
Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications. Cells 11 (20) (2022)
Marco Heestermans, Geraldine Poenou, Anne-Claire Duchez, Hind Hamzeh-Cognasse, Laurent Bertoletti, Fabrice Cognasse
Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases. International journal of molecular sciences 23 (21) (2022)
Marco Heestermans, Clément Naudin, Reiner K Mailer, Sandra Konrath, Kristin Klaetschke, Anne Jämsä, Maike Frye, Carsten Deppermann, Giordano Pula, Piotr Kuta, Nicolaus Kröger, Mathias Gelderblom, Albert Sickmann, Roger J S Preston, Jerzy-Roch Nofer, Stefan Rose-John, Lynn M Butler, Ophira Salomon, Evi X Stavrou, Thomas Renne
Identification of the factor XII contact activation site enables sensitive coagulation diagnostics. Nature communications 12 (1) (2021)
Marco Heestermans, Bart J M van Vlijmen
Oligonucleotides targeting coagulation factor mRNAs: use in thrombosis and hemophilia research and therapy. Thrombosis journal 15 (2017)

Marco Heestermans.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marco Heestermans